Watch: She had a home and a good-paying job. Then illness and debt upended it all.

Syn­dax Phar­ma­ceu­ti­cals won the first FDA ap­proval last week in a new class of med­i­cines called menin in­hibitors. The treat­ment, Re­vu­forj, will be avail­able as

Pregnant patients who received educational video content via text messages about antenatal care for babies born preterm were more prepared for maternal and infant health